Chemoinformaics analysis of Ethyl phenylacetate
Molecular Weight | 164.204 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 0 |
Exact Molecular Weight | 164.084 | nRing | 1 |
Solubility: LogS | -1.444 | nHRing | 0 |
Solubility: LogP | 2.323 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 26.3055 |
nHD | 0 | BPOL | 14.6425 |
QED | 0.556 |
Synth | 2.246 |
Natural Product Likeliness | 1.459 |
NR-PPAR-gamma | 0.018 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.38 |
HIA | 0.005 |
CACO-2 | -4.2 |
MDCK | 0.0000283 |
BBB | 0.965 |
PPB | 0.6314 |
VDSS | 1.126 |
FU | 0.437144 |
CYP1A2-inh | 0.699 |
CYP1A2-sub | 0.897 |
CYP2c19-inh | 0.159 |
CYP2c19-sub | 0.771 |
CYP2c9-inh | 0.066 |
CYP2c9-sub | 0.889 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.354 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.17 |
CL | 9.608 |
T12 | 0.663 |
hERG | 0.026 |
Ames | 0.011 |
ROA | 0.033 |
SkinSen | 0.253 |
Carcinogencity | 0.123 |
EI | 0.989 |
Respiratory | 0.048 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.902062 |